﻿<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<?xml-stylesheet type="text/xsl" href="/css/apdocuments/ap-case.xsl"?>
<apCase>
  <creationDate>2019-08-29</creationDate>
  <apCaseHeader>
    <fileNumbers>
      <fileNumber>3-18826</fileNumber>
    </fileNumbers>
    <respondents>
      <respondent>Golden Claw Ventures, Inc.</respondent>
      <respondent>Q Therapeutics, Inc.</respondent>
      <respondent>Readaboo, Inc.</respondent>
      <respondent>Zika Diagnostics, Inc.</respondent>
    </respondents>
    <caseLink>/litigation/apdocuments/ap-3-18826.xml</caseLink>
  </apCaseHeader>
  <releaseItem>
    <date>2018-09-21</date>
    <releaseNumber>34-84265</releaseNumber>
    <otherReleaseNumbers />
    <title>Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12(j) of the Securities Exchange Act of 1934</title>
    <secLink>/litigation/admin/2018/34-84265.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2019-03-15</date>
    <releaseNumber>34-85329</releaseNumber>
    <otherReleaseNumbers />
    <title>Order to Show Cause</title>
    <secLink>/litigation/opinions/2019/34-85329.pdf</secLink>
  </releaseItem>
  <releaseItem>
    <date>2019-08-29</date>
    <releaseNumber>34-86813</releaseNumber>
    <otherReleaseNumbers />
    <title>Opinion of the Commission</title>
    <secLink>/litigation/opinions/2019/34-86813.pdf</secLink>
  </releaseItem>
</apCase>